Cargando…
A computational evaluation of targeted oxidation strategy (TOS) for potential inhibition of SARS-CoV-2 by disulfiram and analogues
In the new millennium, the outbreak of new coronavirus has happened three times: SARS-CoV, MERS-CoV, and SARS-CoV-2. Unfortunately, we still have no pharmaceutical weapons against the diseases caused by these viruses. The pandemic of SARS-CoV-2 reminds us the urgency to search new drugs with totally...
Autores principales: | Xu, Luyan, Tong, Jiahui, Wu, Yiran, Zhao, Suwen, Lin, Bo-Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161800/ https://www.ncbi.nlm.nih.gov/pubmed/34089978 http://dx.doi.org/10.1016/j.bpc.2021.106610 |
Ejemplares similares
-
Correction to “Synergistic Inhibition of SARS-CoV-2
Replication Using Disulfiram/Ebselen and Remdesivir”
por: Chen, Ting, et al.
Publicado: (2021) -
Tos Ferina : revisión bibliográfica /
por: Presuel Bertruy, Carlos Rubén
Publicado: (1988) -
Tos ferina : revisión bibliográfica
por: Montero Díaz, Hector Rene
Publicado: (1997) -
Synergistic Inhibition of SARS-CoV-2 Replication
Using Disulfiram/Ebselen and
Remdesivir
por: Chen, Ting, et al.
Publicado: (2021) -
Computational identification of disulfiram and neratinib as putative SARS-CoV-2 main protease inhibitors
por: Stroylov, Victor S., et al.
Publicado: (2020)